Beyond-use date: difference between revisions
Diff·revision 29 → 30·05:35, 27 Jan 2026
Difference between revision 29 and revision 30 of Beyond-use date. 2 lines changed; the page grew by 63 bytes.
| Revision 29 — 16:01, 2 Jan 2026 CarryOverCai (talk) expand §Sterile preparations under USP <797> 23,108 bytes ±0 | Revision 30 — 05:35, 27 Jan 2026 StabilityStig (talk) expand §Assignment in the absence of data 23,171 bytes +63 | ||
|---|---|---|---|
| 145 | That third category is where most of the residual confusion sits. The 56-day in-use period on a semaglutide pen and the 28-day default on an unpreserved reconstituted vial look superficially alike and rest on entirely different evidence: one is a labelled claim from a stability programme, the other a borrowed convention. The distinction is developed at [[Temperature excursion]] and at [[Multi-dose vial]].{{r|ppbud}} | 145 | That third category is where most of the residual confusion sits. The 56-day in-use period on a semaglutide pen and the 28-day default on an unpreserved reconstituted vial look superficially alike and rest on entirely different evidence: one is a labelled claim from a stability programme, the other a borrowed convention. The distinction is developed at [[Temperature excursion]] and at [[Multi-dose vial]].{{r|ppbud}} |
| 146 | 146 | ||
| + | 147 | {{seealso|Multi-dose vial|Temperature excursion|Repackaging}} | |
| + | 148 | ||
| 147 | == References == | 149 | == References == |
| 148 | {{reflist}} | 150 | {{reflist}} |